Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Feasibility of biomarker studies for engineered nanoparticles: what can be learned from air pollution research.

Li N, Nel AE.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S74-9. doi: 10.1097/JOM.0b013e31821b1bf2.

2.

Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions.

Stone V, Johnston H, Clift MJ.

IEEE Trans Nanobioscience. 2007 Dec;6(4):331-40. Review.

PMID:
18217626
3.

Potential health impact of nanoparticles.

Xia T, Li N, Nel AE.

Annu Rev Public Health. 2009;30:137-50. doi: 10.1146/annurev.publhealth.031308.100155. Review.

PMID:
19705557
4.

The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles.

Li N, Xia T, Nel AE.

Free Radic Biol Med. 2008 May 1;44(9):1689-99. doi: 10.1016/j.freeradbiomed.2008.01.028. Epub 2008 Feb 13. Review.

5.

[Health risks of engineered nanomaterials and nanotechnologies].

Savolainen K, Vainio H.

Duodecim. 2011;127(11):1097-104. Review. Finnish.

PMID:
21755801
6.

General principles of medical surveillance: implications for workers potentially exposed to nanomaterials.

Trout DB.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S22-4. doi: 10.1097/JOM.0b013e31821b1e45. Review.

7.

Issues in the development of epidemiologic studies of workers exposed to engineered nanoparticles.

Schulte PA, Schubauer-Berigan MK, Mayweather C, Geraci CL, Zumwalde R, McKernan JL.

J Occup Environ Med. 2009 Mar;51(3):323-35. doi: 10.1097/JOM.0b013e3181990c2c. Review.

PMID:
19225418
8.

Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems.

Shvedova AA, Kagan VE, Fadeel B.

Annu Rev Pharmacol Toxicol. 2010;50:63-88. doi: 10.1146/annurev.pharmtox.010909.105819. Review.

PMID:
20055698
9.

Oxidative stress-induced DNA damage by particulate air pollution.

Risom L, Møller P, Loft S.

Mutat Res. 2005 Dec 30;592(1-2):119-37. Epub 2005 Aug 8. Review.

PMID:
16085126
10.

Occupational risk management of engineered nanoparticles.

Schulte P, Geraci C, Zumwalde R, Hoover M, Kuempel E.

J Occup Environ Hyg. 2008 Apr;5(4):239-49. doi: 10.1080/15459620801907840. Review.

PMID:
18260001
11.

Nanomaterials and lung toxicity: interactions with airways cells and relevance for occupational health risk assessment.

Bergamaschi E, Bussolati O, Magrini A, Bottini M, Migliore L, Bellucci S, Iavicoli I, Bergamaschi A.

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4 Suppl):3-10. Review.

PMID:
17291399
12.

Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science.

Schulte PA, Trout D, Zumwalde RD, Kuempel E, Geraci CL, Castranova V, Mundt DJ, Mundt KA, Halperin WE.

J Occup Environ Med. 2008 May;50(5):517-26. doi: 10.1097/JOM.0b013e31816515f7. Review.

PMID:
18469620
13.

Health and safety implications of occupational exposure to engineered nanomaterials.

Stebounova LV, Morgan H, Grassian VH, Brenner S.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 May-Jun;4(3):310-21. doi: 10.1002/wnan.174. Epub 2011 Nov 30. Review.

PMID:
22131295
14.

Nanoparticles: health effects--pros and cons.

Gwinn MR, Vallyathan V.

Environ Health Perspect. 2006 Dec;114(12):1818-25. Review.

15.
16.

Management of nanomaterials safety in research environment.

Groso A, Petri-Fink A, Magrez A, Riediker M, Meyer T.

Part Fibre Toxicol. 2010 Dec 10;7:40. doi: 10.1186/1743-8977-7-40. Review.

17.

[Adverse effects of nanomaterials on biological defense mechanisms].

Higashisaka K.

Yakugaku Zasshi. 2014;134(10):1043-8. Review. Japanese.

18.

Risk management of nanomaterials.

Gwinn MR, Tran L.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Mar-Apr;2(2):130-7. doi: 10.1002/wnan.57. Review.

PMID:
20077523
19.

Occupational health of miners at altitude: adverse health effects, toxic exposures, pre-placement screening, acclimatization, and worker surveillance.

Vearrier D, Greenberg MI.

Clin Toxicol (Phila). 2011 Aug;49(7):629-40. doi: 10.3109/15563650.2011.607169. Epub 2011 Aug 23. Review.

PMID:
21861588
20.

Nanoparticles and the brain: cause for concern?.

Oberdörster G, Elder A, Rinderknecht A.

J Nanosci Nanotechnol. 2009 Aug;9(8):4996-5007. Review.

Items per page

Supplemental Content

Write to the Help Desk